Clinical Trial Update: Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This update summarizes the results of a Phase 2 clinical trial evaluating idarubicin with high-dose cytarabine in patients with acute myeloid leukemia; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-02-06